JNJ
234.31
+0.56%↑
UNH
275.55
-2.98%↓
TMO
563.68
-0.84%↓
ABT
108.15
-0.74%↓
ISRG
478.08
-0.13%↓
JNJ
234.31
+0.56%↑
UNH
275.55
-2.98%↓
TMO
563.68
-0.84%↓
ABT
108.15
-0.74%↓
ISRG
478.08
-0.13%↓
JNJ
234.31
+0.56%↑
UNH
275.55
-2.98%↓
TMO
563.68
-0.84%↓
ABT
108.15
-0.74%↓
ISRG
478.08
-0.13%↓
JNJ
234.31
+0.56%↑
UNH
275.55
-2.98%↓
TMO
563.68
-0.84%↓
ABT
108.15
-0.74%↓
ISRG
478.08
-0.13%↓
JNJ
234.31
+0.56%↑
UNH
275.55
-2.98%↓
TMO
563.68
-0.84%↓
ABT
108.15
-0.74%↓
ISRG
478.08
-0.13%↓
24h
Aktuell
Min
12.88
Max
15.04
Einkommen | 28M 8.2M |
|---|---|
Verkäufe | 351K 351K |
KGV Branchendurchschnitt | 17.216 84.243 |
EPS | 0.94 |
Gewinnspanne | 2,337.322 |
Angestellte | 103 |
EBITDA | 28M 9.3M |
Empfehlungen | Buy |
|---|---|
12-Monats-Prognose | +45.21% upside |
Nächstes Ergebnis | 12. März 2026 |
|---|
Marktkapitalisierung | 3.6M 137M |
|---|---|
Vorheriger Eröffnungskurs | 25.16 |
Vorheriger Schlusskurs | 13.55 |
By Acuity
34%
66%
79 / 352 Ranking in Healthcare
By Trading Central
Vertrauen
Bearish Evidence
N/A / 9.31 Unterstützung & Widerstand
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
5. Feb. 2026, 00:00 UTC
Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul
DJ
Lesen
4. Feb. 2026, 22:55 UTC
Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update
DJ
Lesen
4. Feb. 2026, 21:44 UTC
Arm Holdings 3Q Profit Falls Despite Revenue Growth
DJ
Lesen
4. Feb. 2026, 21:39 UTC
Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook
DJ
Lesen
5. Feb. 2026, 00:00 UTC
Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B
DJ
Lesen
5. Feb. 2026, 00:00 UTC
Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B
DJ
Lesen
4. Feb. 2026, 23:46 UTC
Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk
DJ
Lesen
4. Feb. 2026, 23:45 UTC
Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update
DJ
Lesen
4. Feb. 2026, 23:32 UTC
Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk
DJ
Lesen
4. Feb. 2026, 22:59 UTC
SiTime to Buy Timing Business From Renesas Electronics For $1.5B
DJ
Lesen
4. Feb. 2026, 22:30 UTC
Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com
DJ
Lesen
4. Feb. 2026, 22:30 UTC
Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com
DJ
Lesen
4. Feb. 2026, 22:21 UTC
Snap Stock Pops After Surprise Earnings Beat -- Barrons.com
DJ
Lesen
4. Feb. 2026, 22:17 UTC
WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk
DJ
Lesen
4. Feb. 2026, 22:15 UTC
Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk
DJ
Lesen
4. Feb. 2026, 22:00 UTC
ESG Roundup: Market Talk
DJ
Lesen
4. Feb. 2026, 21:53 UTC
Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update
DJ
Lesen
4. Feb. 2026, 21:51 UTC
Snap Stock Pops After Surprise Earnings Beat -- Barrons.com
DJ
Lesen
4. Feb. 2026, 21:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Lesen
4. Feb. 2026, 21:50 UTC
Financial Services Roundup: Market Talk
DJ
Lesen
4. Feb. 2026, 21:50 UTC
Auto & Transport Roundup: Market Talk
DJ
Lesen
4. Feb. 2026, 21:50 UTC
Health Care Roundup: Market Talk
DJ
Lesen
4. Feb. 2026, 21:45 UTC
Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com
DJ
Lesen
4. Feb. 2026, 21:44 UTC
Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com
DJ
Lesen
4. Feb. 2026, 21:43 UTC
Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update
DJ
Lesen
4. Feb. 2026, 21:41 UTC
These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com
DJ
Lesen
4. Feb. 2026, 21:36 UTC
Latest Canada Green Bond Raises C$2 Billion -- Market Talk
DJ
Lesen
4. Feb. 2026, 21:30 UTC
Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com
DJ
Lesen
4. Feb. 2026, 21:30 UTC
Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com
DJ
Lesen
4. Feb. 2026, 21:30 UTC
Beach Energy Interim Dividend 1 Australian Cent/Sjare
DJ
Lesen
Kursveränderung
By TipRanks
12-Monats-Prognose
Durchschnitt 22 USD 45.21%
Hoch 22 USD
Tief 22 USD
Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Seres Therapeutics Inc – Dist angeboten haben.
By TipRanks
Buy
2 ratings
2
Buy
0
Halten
0
Sell
Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Seres Therapeutics Inc – Dist abgegeben haben.
By Trading Central
Kurzfristig
Bearish Evidence
Recent bearish events outweigh bullish events.
Mittelfristig
Bearish Evidence
All events are bearish.
Langfristig
Bearish Evidence
All events are bearish.
By Acuity
Nachrichtenstimmung
Bullische Evidenz
Volatilität
Unterdurchschnittlich
Nachrichtenvolumen (RCV)
Überdurchschnittlich
Vertriebs- und Verwaltungskosten
Betriebsaufwand
Gewinn vor Steuern
Verkäufe
Umsatzkosten
Bruttogewinn aus dem Verkauf
Zinsaufwand für Schulden
EBITDA
Betriebsergebnis
$